4
Changes in Ownership
AN2 Therapeutics, Inc. Filed Acc 0000950170-23-048436
Director sold 400 shares at $16.00 ($6,400)
From the SEC's structured data for this filing
Trades in this filing
Aziz Kabeer · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-09-13 | Sale : show line 1 in the form | −336 | $16.00 | $5,376 | 2,177,547 | I |
| 2023-09-13 | Sale : show line 2 in the form | −64 | $16.00 | $1,024 | 411,893 | I |
| Open-market sales · 400 sh · avg $16.00 · $6,400 | ||||||
Loading xslF345X05/ownership.xml…